Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update

Seres Therapeutics (MCRB) Reports Q1 Loss of $0.59

May 2, 2019 7:29 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.59), versus ($0.69) reported last year. Revenue for the quarter came in at $7.3 million, versus $3.97 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More